104
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Risk of Atrial Fibrillation, Ischemic Stroke and Cognitive Impairment: Study of a Population Cohort ≥65 Years of Age

ORCID Icon, ORCID Icon, ORCID Icon, , , , , , , , & show all
Pages 445-454 | Published online: 28 Oct 2020

References

  • Ictus: Plan de Actuación en Europa (2018-2030). Ed Stroke Alliance for Europe (SAFE). 2018. www.safestroke.eu. Accessed October 15, 2020.
  • Gabriel SC, Yiin DPJ, Nicola LM. Rothwell, on behalf of the Oxford Vascular Study. Age-specific incidence, outcome, cost, and projected future burden of atrial fibrillation-related embolic vascular events: a population-based study. Circulation. 2014;130(15):1236–1244. doi:10.1161/CIRCULATIONAHA.114.010942
  • Clua-Espuny JL, Piñol-Moreso JL, Panisello-Tafalla A, et al. Estudio Ebrictus. Resultados funcionales, supervivencia y años potenciales de vida perdidos después del primer episodio de ictus. Aten Primaria. 2012;44(4):223–231. doi:10.1016/j.aprim.2011.04.004
  • Proietti M, Laroche C, Opolski G, et al. Investigators. Real-word’ atrial fibrillation management in Europe: observations from the 2-year-follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase. Europace. 2017;19(5):722–733. doi:10.1093/europace/euw112
  • Clua-Espuny JL, Lechuga-Duran I, Bosch-Príncep R, et al. Prevalence of undiagnosed atrial fibrillation and of that not being treated with anticoagulant drugs: the AFABE study. Rev Esp Cardiol. 2013;66:545–552. doi:10.1016/j.rec.2013.03.003
  • Clua-Espuny JL, Piñol-Moreso JL, Panisello-Tafalla A, et al. Resultados de prevención cardiovascular primaria y secundaria en pacientes con ictus. Riesgo de recurrencia y supervivencia asociada. Estudio Ebrictus. Rev Neurol. 2012;54:81–92. doi:10.33588/rn.5402.2011464
  • Ratajczak-Tretel B, Lambert AT, Johansen H, et al. (2019. Atrial fibrillation in cryptogenic stroke and transient ischaemic attack. The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: rationale and design. Eur Stroke J. 2019;4(2):172–180. doi:10.1177/2396987319837089
  • Hachinskia V, Einhauplb K, Gantenc D, et al. Preventing dementia by preventing stroke: the Berlin Manifesto. Alzheimer’s & Dementia. 2019;15:961–984. doi:10.1016/j.jalz.2019.06.001
  • Schnabel RB, Haeusler KG, Healey JS, Freedman B, Boriani G, Brachmann J. Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration. Circulation. 2019;140(22):1834–1850. doi:10.1161/CIRCULATIONAHA.119.040267
  • Kirchhhof P, et al. ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration with EACTS. Rev Esp Cardiol (Engl Ed), 2017. 70 (1):50.documento de consenso de múltiples sociedades (EHRA, HRS, APHRS y SOLAECE). Europace. 2016;2017(19):1589–1623. doi:10.1093/ejcts/ezw313
  • Moran PS, Teljeur C, Ryan M, Smith SM. Systematic screening for the detection of atrial fibrillation. Cochrane Database Syst Rev. 2016;6:. doi:10.1002/14651858.CD009586.pub3
  • Vermond RA, Geelhoed B, Verweij N, et al. Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality. A Community-Based Study From the Netherlands. J Am Coll Cardiol. 2015;66(9):1000–1007. doi:10.1016/j.jacc.2015.06.1314
  • Clua-Espuny JL, Muñoz Perez MA, Bustamante-Rangel A, Montaner Villalonga J, Pedrote Martínez AA on behalf members of AFRICAT Group. Stepwise High Risk Individuals Screening for Atrial Fibrillation Using Sequential Clinical-electro-biological Register: the AFRICAT Study (Atrial Fibrillation Research In CATalonia). ClinicalTrials. 2020.
  • Uittenbogaart SB, Gurp NV-V, Petra MG, et al. Stoffers. Detecting and Diagnosing Atrial Fibrillation (D2AF): study protocol for a cluster randomised controlled trial. Trials. 2015;16:478. doi:10.1186/s13063-015-1006-5
  • Thijs V. Atrial Fibrillation Detection. Fishing for An Irregular Heartbeat Before and After Stroke. Stroke. 2017;48(10):2671–2677. doi:10.1161/STROKEAHA.117.017083
  • Muria-Subirats E, Clua-Espuny JL, Ballesta-Ors J, Lorman-Carbó B, Lechuga-Durán I, Fernández-Sáez J. Pla-Farnós R. Incidence and Risk Assessment for Atrial Fibrillation at 5 Years: hypertensive Diabetic Retrospective Cohort. Int J Environ Res. 2020;17(10):3491. doi:10.3390/ijerph17103491
  • Blay C, Limón E (Coord.) Bases para un modelo catalán de atención a las personas con necesidades complejas: conceptualización e introducción a los elementos operativos. [Internet] Barcelona: departament de Salut; 2016. Available from: http://salutweb.gencat.cat/web/.content/_ambits-actuacio/Linies-dactuacio/Estrategies-de-salut/Cronicitat/Documentacio-cronicitat/arxius/bases_modelo_personas_complejidad_v_6.pdf. Accessed October 15, 2020.
  • Özcan EE. Bülent Görenek1. Lessons from the current European Heart Rhythm Association consensus document on screening for atrial fibrillation. Anatol J Cardiol. 2018;19:222–224. doi:10.14744/AnatolJCardiol.2018.37043
  • Ballesta-Ors J, Clua-Espuny JL, Gentille-Lorente DI, et al. Results, barriers and enablers in atrial fibrillation case finding: barriers in opportunistic atrial fibrillation case finding-a cross-sectional study. Fam Pract. 2020;27:pii: cmaa023. doi:10.1093/fampra/cmaa023
  • Zungsontiporn N, Link MS. Newer technologies for detection of atrial fibrillation. BMJ. 2018;363:k3946. doi:10.1136/bmj.k3946
  • Kaplan RM, Koehler J, Ziegler PD, Sarkar S, Zweibel S, Passman RS. Stroke Risk as a Function of Atrial Fibrillation Duration and CHA 2 DS 2-VASc Score. Circulation. 2019;140(20):1639–1646. doi:10.1161/CIRCULATIONAHA.119.041303
  • Bayés-de-Luna A, Martínez-Sellés M, Elosua R, et al. Relation of Advanced Interatrial Block to Risk of Atrial Fibrillation and Stroke. Am J Cardiol. 2020;16:pii: S0002-9149(20)30208–3. doi:10.1016/j.amjcard.2020.02.034
  • Haeusler KG, Tütüncü S, Schnabel RB. Detection of Atrial Fibrillation in Cryptogenic Stroke. Curr Neurol Neurosci Rep. 2018;18(10):66. doi:10.1007/s11910-018-0871-
  • Lowres N, Olivier J, Chao TF, et al. Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single times screening: a multi country patient-level meta-analysis of 141,220 screened individuals. PLoS Med. 2019;16(9):e1002903. doi:10.1371/journal.pmed.1002903
  • Efremov L, Lacruz ME, Tiller D, et al. Metabolically Healthy, but Obese Individuals and Associations with Echocardiographic Parameters and Inflammatory Biomarkers: results from the CARLA Study. Diabetes Metabolic Syndrome Obesity. 2020;13:2653–2665. doi:10.2147/DMSO.S263727
  • Middeldorp ME, Ariyaratnam J, Lau D, Sanders P. Lifestyle modifications for treatment of atrial fibrillation. Heart. 2020;106(5):325–332. doi:10.1136/heartjnl-2019-315327
  • Lau ES, Paniagua SM, SawallaGuseh J, et al. Sex Differences in Circulating Biomarkers of Cardiovascular Disease. J Am Coll Cardiol. 2019;74:12. doi:10.1016/j.jacc.2019.06.077
  • García-Berrocoso T, Palà E, Consegal M, et al. Cardioembolic Ischemic Stroke Gene Expression Fingerprint in Blood: a Systematic Review and Verification Analysis. Transl Stroke Res. 2019. doi:10.1007/s12975-019-00730-x
  • Palà E, Bustamante A, Clúa-Espuny JL, et al. N-Terminal Pro B-Type Natriuretic Peptide’s Usefulness for Paroxysmal Atrial Fibrillation Detection Among Populations Carrying Cardiovascular Risk Factors. Front Neurol. 2019;10:1226. doi:10.3389/fneur.2019.01226
  • Wu VC, Wu M, Aboyans V, et al. Female sex as a risk factor for ischaemic stroke varies with age in patients with atrial fibrillation. Heart. 2019;26:pii: heartjnl-2019-315065. doi:10.1136/heartjnl-2019-315065
  • Cuixart CB. Recomendaciones preventivas cardiovasculares. Actualización PAPPS. 2018. doi:10.1016/S0212-6567(18)30360-3
  • Gillis C, Mirzaei F, Potashman M, Ikram MA, Maserejian N. The incidence of mild cognitive impairment: A systematic review and data synthesis. Alzheimers Dement. 2019;11:248–256. doi:10.1016/j.dadm.2019.01.004
  • Kim D, Yang PS, Yu HT, et al. Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort. Eur Heart J. 2019;40(28):2313–2323. doi:10.1093/eurheartj/ehz386
  • Dagres N, Chao TF, Fenelon G, et al. Zhang S and Chung MK. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice? Heart Rhythm. 2018;15:e37–e60.
  • Lei C, Deng Q, Haijiang L, Zhong L. Association Between Silent Brain Infarcts and Cognitive Function: A Systematic Review and Meta-Analysis. J Stroke Cerebrovascular Dis. 2019;28:2376–2387. doi:10.1016/j.jstrokecerebrovasdis.2019.03.036
  • Carline J. Integrated management of atrial fibrillation in primary care: results of the ALL-IN cluster randomized trial. Eur Heart J. 2020;ehaa055. doi:10.1093/eurheartj/ehaa055
  • Friberg L, Andersson T, Rosenqvist M. Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation. Eur Heart J. 2019;40(28):2327–2335. doi:10.1093/eurheartj/ehz304
  • Gallinoro E, D’Elia S, Prozzo D, et al. Cognitive Function and Atrial Fibrillation: from the Strength of Relationship to the Dark Side of Prevention. Is There a Contribution from Sinus Rhythm Restoration and Maintenance? Medicina. 2019;55(9):587. doi:10.3390/medicina55090587
  • Rivard L, Mechanisms KP, Significance C. Prevention of Cognitive Impairment in Patients with Atrial Fibrillation. Can J Cardiol. 2017;33(12):1556–1564. doi:10.1016/j.cjca.2017.09.024